US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ドイツ
TG
Rock Tech Lithium Inc (RJIB) 銘柄情報

Rock Tech Lithium Inc (RJIB)

0.468

0.001

(0.21%)

終了 7月11日 5:00AM

Rock Tech Lithium Inc (RJIB) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.468

( 0.21% )

買値

0.46

売値

0.475

出来高

63,880

平均取引量 (3 か月)

23,394 €

財務取引量

-

0.462 日の範囲 0.483

0.00 52 週間の範囲 0.00

時価総額

企業価値

89.148M

前日終値

0.467

始値

0.48

時刻

最終取引時間

VWAP

-

歳入

-

純利益

-11.98M

発行済株式数

119,999,985

浮動株比率 (%)

92.46%

機関投資家保有比率 (%)

0.31%

配当利回り

PER

-7.37

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-0.11

ベータ

1.87

Rock Tech Lithium Inc. engages in the exploration and development of lithium properties. It primarily focuses on developing and optimizing battery grade lithium hydroxide monohydrate. It holds a 100% interest in the Georgia Lake lithium project located in the Thunder Bay Mining District of Ontario. ... Rock Tech Lithium Inc. engages in the exploration and development of lithium properties. It primarily focuses on developing and optimizing battery grade lithium hydroxide monohydrate. It holds a 100% interest in the Georgia Lake lithium project located in the Thunder Bay Mining District of Ontario. The company was formerly known as Rock Tech Resources Inc. and changed its name to Rock Tech Lithium Inc. in April 2010. Rock Tech Lithium Inc. was incorporated in 2010 and is headquartered in Toronto, Canada. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.rocktechlithium.com

本社

Toronto, Canada

設立

2026

Rock Tech Lithium Inc is listed in the sector of the Tradegate (DE) with ticker RJIB. The last closing price for Rock Tech Lithium was 0.47 €. Over the last year, Rock Tech Lithium shares have traded in a share price range of 0.00 € to 0.00 €.

Rock Tech Lithium currently has 119,999,985 shares in issue. The market capitalisation of Rock Tech Lithium is 56.16 € million. Rock Tech Lithium has a price to earnings ratio (PE ratio) of -7.37.

Original-Research: Rock Tech Lithium Inc (von Montega AG): -

Original-Research: Rock Tech Lithium Inc - von Montega AG Einstufung von Montega AG zu Rock Tech Lithium Inc Unternehmen: Rock Tech Lithium...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

RJIB - Frequently Asked Questions (FAQ)

What is the current Rock Tech Lithium Inc share price?

The current share price of Rock Tech Lithium Inc is 0.468 €

How many Rock Tech Lithium Inc shares are in issue?

Rock Tech Lithium Inc has 119,999,985 shares in issue

What is the market cap of Rock Tech Lithium Inc?

The market capitalisation of Rock Tech Lithium Inc is EUR 56.16M

What is the 1 year trading range for Rock Tech Lithium Inc share price?

Rock Tech Lithium Inc has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Rock Tech Lithium Inc?

The price to earnings ratio of Rock Tech Lithium Inc is -7.37

What is the registered address of Rock Tech Lithium Inc?

The registered address for Rock Tech Lithium Inc is 40 Temperance Street, Toronto, Ontario, M5H 0B4

What is the Rock Tech Lithium Inc website address?

The website address for Rock Tech Lithium Inc is www.rocktechlithium.com

Sleepy$$$

Sleepy$$$ 42分前

Added a few k yesterday and bidding. Funny this one gets no attention. .07 - $15

Paul Brentjens

Paul Brentjens 48分前

yes, got that message too, yesterday morning.
Temporary error I guess, on CS..
Works again

WooptdooU

WooptdooU 50分前

Lwlg's No risk, Grifter, current leader has a greatest fear and the shorts seems to know the situation.
Whi would replace yves? Seems there are several who can spin the same wheels.

Teddytropics

Teddytropics 55分前

Thanks for showing yourself..

For new eyes, the linked material being presented as relevant is 4 years old from the Old CEO.

Currently he has nothing to do with the company and there has been zero evidence presented by;

The Pro-Bas

Mr79

Mr79 1時間前

https://media4.giphy.com/media/v1.Y2lkPTZjMDliOTUydTl4Ynh6azU1ZjkxeDd3YXgyb2FkOHF6ZXdqZHd3dHdueGJranM1NCZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/hwvbZ1kHDPdAs/giphy.gifhttps://media0.giphy.com/media/v1.Y2lkPTZjMDliOTUycTk4c3EzaWFoMm4xZTZjbXFieGFybGphZng0cW9uODZoeDZka2d4diZlcD12MV9pbnRlcm5hbF9naWZfYn

Nytoncva

Nytoncva 1時間前

He may have already raised a chunk this past week, obviously not 9M, but anyone know what volume the first day was? Yesterday was less than average at only 700k. That really felt like dilution on day 1. Even with the poor PR, in this market environment I really would have expected more strength. I

Squirrely_McShitty

Squirrely_McShitty 1時間前

I assume you're talking smack to lower the price.

Yes, 432m shares outstanding with 600m authorized is simply horrible for an OTC company, lol. Claude Solitario is a bum too, aye?

Claude Solitario, for those who don't know, co-founded Invatec Health, a private company,

Nemesis18

Nemesis18 1時間前

If all was well, NWBO wouldn't have needed to do the latest 'data drag net' presentation. It smacks of a last desperate hail mary pass to satisfy both the MHRA and NICE forensic statisticians.

Nemesis18

Nemesis18 2時間前

>>Yep... all those people who had GBM and are alive 8, 10, 12 years later really agree with your opinion.... clown!!! 🙄

eagle8

eagle8 2時間前

Not that i know.

GLTU

DTGoody

DTGoody 2時間前

They're going to reverse merge with a Medical Courier Driver from PA to Deliver Anti-Depressants to the ENCC Shareholders who sold their shares right before a massive reverse merger happened! LOL :))

chereb19

chereb19 2時間前

This post is a good reminder that confidence and accuracy aren't the same thing. You predicted the FDA wouldn't "give the green light." The FDA subsequently approved the IDE to begin the human feasibility study. It's perfectly reasonable to remain skeptical, but it's also reasonable to acknowledge w

Wallstreeter$$$

Wallstreeter$$$ 2時間前

Typical lazy DD Norman cuz u wouldve seen I later said I would hold a core position in Vivos longer term. Btw numbnuts I've been swing trading this from day one, sometimes taking small profits but reinvesting most of it in new stock. Heck i've been increasing my position without spending one red cen

searay2701

searay2701 3時間前

I suggest that folks check BRC Laboratory com. A test has been completed on Insultex but it shows no completion date, could this one with no date on it be from an earlier testing than the one we are currently waiting for?

PickStocks

PickStocks 3時間前

Bill becomes law?

north40000

north40000 3時間前

“Cost-saving legislation in healthcare passed by German parliament didn’t help matters either.

murrayhill

murrayhill 3時間前

O'Jays - Backstabber
https://www.youtube.com/watch?v=RmXRQ3vfzcA

flipper44

flipper44 3時間前

Hi Baxers, I just don’t buy that a proposed refusal occurred followed by an appeal.

Perhaps this is one of those rare moments opposite forces align to try and make NWBO spill the beans.

Regardless, the way the system works, according to MHRA, is that CTBVEAG does not ma

janice shell

janice shell 3時間前

You know all the fuss that's being made about the tacky "Freedom Fuel" gas stations that have popped up in Southeast Pennsylvania and part of New Jersey...

All over the news for several days now. It's a mystery!! Who owns them? Some Trump buddy? Very likely, but oddly enough, nobody

shajandr

shajandr 4時間前

Dave:

Prison - you're nott gonna like big boy prison.

https://investorshub.advfn.com/uimage/uploads/2026/7/11/exmlgbeaumont.jpg
https://investorshub.advfn.com/uimage/uploads/2014/3/21/m[igcinmateArrival.jpg
https://investorshub.advfn.com/uimage/uploads/202

chereb19

chereb19 4時間前

Every time you're wrong, you don't revisit your thesis—you just invent a new one. First it was "they'll never get an IDE." Then it became "it's only an EFS IDE." Now it's dilution, patents and OTC. The conclusion never changes; only the excuse does.

You're throwing everything at the w

Rock Tech Lithium

InMed Pharmaceuticals

Jpmorgan Chase Bank Na P...

Willow Lane Acquisition

Action Televerbier

Wrst Fxd Cpn Nts Lkd Bkt...

Newport Logistica Fundo ...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。